MK2-IN-1 hydrochloride NEW
| Price | $31 | $53 | $109 |
| Package | 5mg | 10mg | 25mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-15 |
Product Details
| Product Name: MK2-IN-1 hydrochloride | CAS No.: 1314118-94-9 |
| Purity: 99.67% | Supply Ability: 10g |
| Release date: 2026/07/15 |
Product Introduction
Bioactivity
| Name | MK2-IN-1 hydrochloride |
| Description | MK2-IN-1 hydrochloride (MK 25) is a highly selective, non-ATP competitive inhibitor of p38/mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2 or MK2, IC50: 0.11 μM) [1]. |
| In vitro | MK2-IN-1 has been shown to inhibit pro-inflammatory cytokine secretion from the human THP-1 acute monocytic leukemia cell line, causing inhibition of LPS-stimulated TNF-α (IC50: 4.4 μM) and IL-6 (IC50: 5.2 μM) secretion.1 It can also inhibit IL-1β-stimulated matrix-metalloprotease 13 secretion from the SW1353 chondrosarcoma cell line (IC50: 5.7 μM) and human primary chondrocyte cultures (IC50: 2.2 μM) [1]. |
| Storage | Store under nitrogen, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 1 mg/mL (1.96 mM), Sonication is recommended. DMSO : 50 mg/mL (98.15 mM), Sonication is recommended. H2O : Insoluble |
| Keywords | MK2-IN-1 Hydrochloride | MK-2-IN-1 hydrochloride | MK2IN1 hydrochloride | MK-25 | MK25 | MK2 IN 1 hydrochloride | MK2 | Mitogen-activated protein kinase activated protein kinase 2 | MAPKAPK2 (MK2) | MAPKAP kinase 2 | MAPK activated protein kinase 2 | MAP kinase activated protein kinase 2 | Inhibitor | inhibit |
| Inhibitors Related | Ethoxyquin | Phosphocreatine disodium hydrate | Tamoxifen | Vemurafenib | Palmitic acid sodium | Mequinol | 7-Aminocephalosporanic acid | Phosphocreatine disodium | Benzbromarone | Palmitic acid | Tamoxifen Citrate | Sodium new houttuyfonate |
| Related Compound Libraries | Osteogenesis Compound Library | Nonsteroidal Anti-Inflammatory Compound Library | Anti-Colorectal Cancer Compound Library | Reprogramming Compound Library | Pain-Related Compound Library | Bioactive Compound Library | Kinase Inhibitor Library | Anti-Ovarian Cancer Compound Library | Inhibitor Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-Liver Cancer Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1980.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-05-11 | |
| $35.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-07-14 | |
| $200.00 |
VIP3Y
|
Henan Fengda Chemical Co., Ltd
|
2026-07-09 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY